Patient Advocacy in 2023: A Look Back at Advocacy Efforts, Patient Concerns

Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds

IASLC Calls For Documentation of Tobacco Use in Cancer Clinical Trials

Modified Lung Cancer Screening Eligibility Requirements May Reduce Racial Disparities in Lung Cancer Screening, Treatment

Mesothelioma Patients Experienced Higher Levels of Toxicity on CheckMate743 Regimen Than Reported in Clinical Trials

IASLC Announces Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic Cancers

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

Patterns of Failure after PACIFIC: How to Address Disease Recurrence after Chemoradiotherapy and Immunotherapy

Research Supports Use of Lung Nodule Programs to Improve Early Detection Efforts

US FDA Announces Multiple Moves with Implications for Lung Cancer Care

In Brief for January 10, 2024

Artificial Intelligence in Thoracic Radiation Oncology: Patient Evaluation and Treatment Planning